TITLE

CLINIC ROUNDUP

PUB. DATE
May 2008
SOURCE
BioWorld Today;5/6/2008, Vol. 19 Issue 88, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
This section offers news briefs on the pharmaceutical industry. Anesiva Inc. has announced the publication of data from a Phase III trial of Zingo powder intradermal injection in "Journal Pediatrics." Can-Fite BioPharma has successfully completed a Phase I trial with its second pipeline drug, CF102, for the treatment of liver disease. A Phase II trial has been initiated by Curis Inc. for its GDC-0449 drug for treating metastatic colorectal cancer.
ACCESSION #
31949932

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics